<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[Cyclacel Pharmaceuticals Inc. | Company News & Executive Profiles - CYCC | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/cyclacel+pharmaceuticals+inc..html?i=11]]></link>
	<description><![CDATA[Latest company news & analysis, recent events, stock quotes, earning call transcripts, with profiles and descriptions of top business executives for Cyclacel Pharmaceuticals Inc.]]></description>
	<s:counts start="0" returned="10" found="10" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Cyclacel to Present at Collins Stewart Fourth Annual Growth Conference]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_July_2/ai_n27878544]]></link>
		<description><![CDATA[BERKELEY HEIGHTS, N.J. -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC), (NASDAQ: CYCCP) announced today that John Womelsdorf, Ph.D., Vice President, Business Development, will present an overview of the Company at the Collins Stewart 4th Annual Growth Conference taking place at the Mandarin Oriental Hotel in New York. Dr. Womelsdorf's presentation will...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 02 Jul 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/cyclacel+pharmaceuticals+inc..html"><![CDATA[Cyclacel Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[HEALTHCARE]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CYCC</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="tickers">CYCC,NDAQ</category>
	</item>
	<item>
		<title><![CDATA[Cyclacel Pharmaceuticals Announces May 2008 Corporate Events]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_April_28/ai_n25359649]]></link>
		<description><![CDATA[-- NASDAQ Bell Closing on May 8 --  -- Release of 1Q08 Financial Results/Conference Call on May 9 --  -- Annual Shareholders Meeting on May 14 --  BERKELEY HEIGHTS, N.J. -- Cyclacel Pharmaceuticals, Inc. (NASDAQ:CYCC)(NASDAQ:CYCCP) has announced certain corporate events that will take place during May 2008....]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 28 Apr 2008 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/cyclacel+pharmaceuticals+inc..html"><![CDATA[Cyclacel Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/financial.html"><![CDATA[financial]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[HEALTHCARE]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CYCC</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="tickers">CYCC,NDAQ</category>
	</item>
	<item>
		<title><![CDATA[Update - Cyclacel to Host Conference Call December 19 - Note New Time]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2007_Dec_18/ai_n27478022]]></link>
		<description><![CDATA[BERKELEY HEIGHTS, N.J. -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) (NASDAQ: CYCCP) will host a conference call featuring Dr. Hagop Kantarjian, M.D. to provide an update of sapacitabine Phase II clinical plans in patients with elderly AML, review Phase I sapacitabine data reported at the meeting of the American Society of...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 18 Dec 2007 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/cyclacel+pharmaceuticals+inc..html"><![CDATA[Cyclacel Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[HEALTHCARE]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[patient]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CYCC</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="tickers">CYCC,NDAQ</category>
	</item>
	<item>
		<title><![CDATA[Cyclacel Pharmaceuticals to Present at the NYSSA 11th Annual Biotech/Specialty Pharma Conference]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2007_Dec_6/ai_n27467420]]></link>
		<description><![CDATA[BERKELEY HEIGHTS, N.J. -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP) announced today that Spiro Rombotis, President and CEO, will present at the 11th Annual Biotech/Specialty Pharma Conference hosted by the New York Society of Security Analysts NYSSA taking place on Tuesday and Wednesday, December 11 and 12, 2007. The...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 06 Dec 2007 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/conference.html"><![CDATA[conference]]></category>
		<category domain="http://resources.bnet.com/topic/cyclacel+pharmaceuticals+inc..html"><![CDATA[Cyclacel Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[HEALTHCARE]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CYCC</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="tickers">CYCC,NDAQ</category>
	</item>
	<item>
		<title><![CDATA[Cyclacel Pharmaceuticals Announces Sapacitabine Poster Presentation at Upcoming American Society of Hematology Meeting]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2007_Dec_5/ai_n27466956]]></link>
		<description><![CDATA[BERKELEY HEIGHTS, N.J. -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP) announced today updated Phase I clinical trial results of sapacitabine for the treatment of advanced leukemias or myelodysplastic syndromes will be presented at the 2007 American Society of Hematology ASH 49th Annual Meeting in Atlanta, GA, on Saturday, December...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 05 Dec 2007 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/cyclacel+pharmaceuticals+inc..html"><![CDATA[Cyclacel Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[HEALTHCARE]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CYCC</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="tickers">CYCC,NDAQ</category>
	</item>
	<item>
		<title><![CDATA[Cyclacel Pharmaceuticals to Present at the Lazard Capital Markets 4th Annual Healthcare Conference]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2007_Nov_14/ai_n27445313]]></link>
		<description><![CDATA[BERKELEY HEIGHTS, N.J. -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP) announced today that Spiro Rombotis, President and CEO, will present an overview of the Company and its pipeline at the Lazard Capital Markets 4th Annual Healthcare Conference. Mr. Rombotis' presentation will take place on Tuesday, November 27, 2007 at...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 14 Nov 2007 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/cyclacel+pharmaceuticals+inc..html"><![CDATA[Cyclacel Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[HEALTHCARE]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CYCC</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="tickers">CYCC,NDAQ</category>
	</item>
	<item>
		<title><![CDATA[Cyclacel Pharmaceuticals to Announce Third Quarter 2007 Financial Results on November 7, 2007]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2007_Nov_2/ai_n21080398]]></link>
		<description><![CDATA[BERKELEY HEIGHTS, N.J. -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) (NASDAQ: CYCCP) will announce third quarter 2007 financial results on November 7, 2007. The company will host a conference call and live webcast at 10:00 am EST.  Conference call information:  US/Canada call: 888-603-6873; conference code 9425576  International call:...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 02 Nov 2007 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/cyclacel+pharmaceuticals+inc..html"><![CDATA[Cyclacel Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/financial.html"><![CDATA[financial]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[HEALTHCARE]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/webcast.html"><![CDATA[Webcast]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CYCC</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="tickers">CYCC,NDAQ</category>
	</item>
	<item>
		<title><![CDATA[Cyclacel Pharmaceuticals to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2007_Oct_25/ai_n27421275]]></link>
		<description><![CDATA[BERKELEY HEIGHTS, N.J. -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC) (NASDAQ: CYCCP) announced today that Spiro Rombotis, President and CEO, will present an overview of the Company and its pipeline at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference. Mr. Rombotis' presentation will take place on Monday, November 5,...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 25 Oct 2007 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/cyclacel+pharmaceuticals+inc..html"><![CDATA[Cyclacel Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[HEALTHCARE]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CYCC</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="tickers">CYCC,NDAQ</category>
	</item>
	<item>
		<title><![CDATA[Cyclacel Reports Phase I Sapacitabine Data in Patients with Advanced Leukemias and Myelodysplastic Syndromes at 2007 ASCO Annual Meeting]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2007_June_2/ai_n19188496]]></link>
		<description><![CDATA[BERKELEY HEIGHTS, N.J. -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP) reported interim results from a Phase I clinical trial of sapacitabine (CYC682), a novel orally available nucleoside analog, in patients with advanced leukemias or myelodysplastic syndromes MDS. The data demonstrated that sapacitabine had a favorable safety profile and promising...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Sat, 02 Jun 2007 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/asco+plc..html"><![CDATA[Asco Plc.]]></category>
		<category domain="http://resources.bnet.com/topic/cyclacel+pharmaceuticals+inc..html"><![CDATA[Cyclacel Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CYCC</category>
		<category domain="tickers">CYCC</category>
	</item>
	<item>
		<title><![CDATA[Rodman & Renshaw 3rd Annual Global Healthcare Conference 2006 Presenter Profiles]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2006_May_12/ai_n26860611]]></link>
		<description><![CDATA[MONTE CARLO, Monaco -- Rodman & Renshaw 3rd Annual Global Healthcare Conference 2006 takes place May 15-16 in Monte Carlo.  For in-depth information about the event visit http://www.rodmanandrenshaw.com/Conferences.asp?CID=conf9.  Below are profiles from Rodman & Renshaw 3rd Annual Global Healthcare Conference 2006 presenters; breaking news releases are available at...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 12 May 2006 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/amex.html"><![CDATA[AMEX]]></category>
		<category domain="http://resources.bnet.com/topic/arbios+systems+inc..html"><![CDATA[Arbios Systems Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/bentley+pharmaceuticals+inc..html"><![CDATA[Bentley Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/biomarin+pharmaceutical+inc..html"><![CDATA[BioMarin Pharmaceutical Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/biotechnology.html"><![CDATA[biotechnology]]></category>
		<category domain="http://resources.bnet.com/topic/ceragenix+pharmaceuticals+inc..html"><![CDATA[Ceragenix Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/company.html"><![CDATA[Company]]></category>
		<category domain="http://resources.bnet.com/topic/compound.html"><![CDATA[compound]]></category>
		<category domain="http://resources.bnet.com/topic/cyclacel+pharmaceuticals+inc..html"><![CDATA[Cyclacel Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/cytogen+corp..html"><![CDATA[Cytogen Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/cytrx+corp..html"><![CDATA[CytRx Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/dyadic+international+inc..html"><![CDATA[Dyadic International Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/entremed+inc..html"><![CDATA[EntreMed Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/gammacan+international+inc..html"><![CDATA[GammaCan International Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/genta+inc..html"><![CDATA[Genta Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/insmed+inc..html"><![CDATA[Insmed Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/inyx+inc..html"><![CDATA[Inyx Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/medivation+inc..html"><![CDATA[Medivation Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/nasdaq+stock+market+inc..html"><![CDATA[Nasdaq Stock Market Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/parkinson.html"><![CDATA[Parkinson]]></category>
		<category domain="http://resources.bnet.com/topic/patient.html"><![CDATA[patient]]></category>
		<category domain="http://resources.bnet.com/topic/phone.html"><![CDATA[phone]]></category>
		<category domain="http://resources.bnet.com/topic/provectus+pharmaceuticals+inc..html"><![CDATA[Provectus Pharmaceuticals Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/technology.html"><![CDATA[technology]]></category>
		<category domain="http://resources.bnet.com/topic/therapy.html"><![CDATA[therapy]]></category>
		<category domain="http://resources.bnet.com/topic/ticker.html"><![CDATA[ticker]]></category>
		<category domain="http://resources.bnet.com/topic/web.html"><![CDATA[Web]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ABOS</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BNT</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">BMRN</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CGXP</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CYCC</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CYTO</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">CYTR</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">DYAI</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">ENMD</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GCAN</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">GNTA</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">INSM</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">IYXI</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">MDVN</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NDAQ</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PVCT</category>
		<category domain="tickers">ABOS,BNT,BMRN,CGXP,CYCC,CYTO,CYTR,DYAI,ENMD,GCAN,GNTA,INSM,IYXI,MDVN,NDAQ,PVCT</category>
	</item>
</channel>
</rss>
